NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment - Nanoviricides (AMEX:NNVC)
Read the latest report on NanoViricides here.
Source: benzinga.com